New Zealand - engelsk - Medsafe (Medicines Safety Authority)

viatris limited - ceftriaxone sodium 1.079 g equivalent to 1 g ceftriaxone (anhydrous) - powder for injection - 1 g - active: ceftriaxone sodium 1.079 g equivalent to 1 g ceftriaxone (anhydrous) - infections caused by pathogens sensitive to ceftriaxone e.g.: - sepsis; - meningitis; - abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); - infections of the bones, joints, soft tissue, skin and of wounds; - infections in patients with impaired defence mechanisms; - renal and urinary tract infections; - respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; - genital infections, including gonorrhoea. - perioperative prophylaxis of infections.

Malta - engelsk - Malta Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 250 mg - antibacterials for systemic use

Malta - engelsk - Malta Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 500 mg - antibacterials for systemic use

Malta - engelsk - Malta Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 1 g - antibacterials for systemic use

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ceftriaxone sodium -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ceftriaxone sodium -

Malta - engelsk - Malta Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftriaxone sodium - powder for solution for infusion - ceftriaxone sodium 2 gram(s) - antibacterials for systemic use

Malta - engelsk - Malta Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for infusion - ceftriaxone sodium 2 g - antibacterials for systemic use

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

devatis limited - ceftriaxone sodium 2.386 g equivalent to ceftriaxone 2g - powder for infusion - 2 g - active: ceftriaxone sodium 2.386 g equivalent to ceftriaxone 2g - infections caused by pathogens sensitive to ceftriaxone, e.g.: - sepsis - meningitis - abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts) - infections of the bones, joints, soft tissue, skin and of wounds; - infections in patients with impaired defence mechanisms - renal and urinary tract infections - respiratory tract infections, particularly pneumonia, and ear, nose and throat infections - genital infections, including gonorrhoea - perioperative prophylaxis of infections.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

devatis limited - ceftriaxone sodium 0.596 g equivalent to ceftriaxone 0.5g - powder for injection - 0.5 g - active: ceftriaxone sodium 0.596 g equivalent to ceftriaxone 0.5g - infections caused by pathogens sensitive to ceftriaxone, e.g.: - sepsis - meningitis - abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts) - infections of the bones, joints, soft tissue, skin and of wounds; - infections in patients with impaired defence mechanisms - renal and urinary tract infections - respiratory tract infections, particularly pneumonia, and ear, nose and throat infections - genital infections, including gonorrhoea - perioperative prophylaxis of infections.